This study assessed perceptions of pre-exposure prophylaxis (PrEP) and their association with PrEP adoption intention among a convenience sample of 224 low socioeconomic status black men who have sex with men (BMSM) residing in Los Angeles. Participants received educational information about PrEP and completed an in-person interview. More than half (60%) of the participants indicated a high intention to adopt PrEP. Younger BMSM (18–29 years) were twice as likely to report a high intention to adopt PrEP compared to older BMSM (30+ years). Only 33% of participants were aware of PrEP and no participant had ever used PrEP. Negative perceptions were associated with a lower PrEP adoption intention and included being uncomfortable taking an HIV medicine when HIV-negative and not knowing if there are long-term side effects of taking an HIV medication. These findings suggest that BMSM may adopt PrEP but that negative perceptions may limit its uptake among this population. In order to facilitate PrEP adoption among BMSM targeted educational and community awareness programmes are needed to provide accurate information on the benefits of PrEP and to address the negative perceptions of PrEP held by local BMSM populations.
Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012. Available at: http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf (2012, accessed September 2014).
3.
Rotheram BorusMJSwendemanDChovnickG. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Ann Rev Clin Psychol2009; 5: 143–67.
4.
PetersonJLJonesKT. HIV prevention for black men who have sex with men in the United States. Am J Public Health2009; 99: 976–980.
5.
BaetenJMDonnellDNdaseP, et al.Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med2012; 367: 399–410.
6.
GrantRMLamaJRAndersonPL, et al.Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med2010; 363: 2587–2599.
7.
ThigpenMCKebaabetswePMPaxtonLA, et al.Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med2012; 367: 423–434.
8.
CohenMSMcCauleyMGambleTR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS2012; 7: 99–105.
9.
BaileyRCMosesSParkerCB, et al.Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet2007; 369: 643–656.
10.
GrayRHKigoziGSerwaddaD, et al.Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet2007; 369: 657–666.
11.
KibengoFMRuzagiraEKatendeD, et al.Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS ONE2013; 8: e74314–e74314.
12.
Abdool KarimQAbdool KarimSSFrohlichJA, et al.Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science2010; 329: 1168–1174.
13.
Quinones-MateuMEVanhamG. HIV microbicides: where are we now?Curr HIV Res2012; 10: 1–2.
14.
ParisRMKimJHRobbML, et al.Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. Expert Rev Vaccines2010; 9: 1055–1069.
15.
VaccariMPoonamPFranchiniG. Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV. Expert Rev Vaccines2010; 9: 997–1005.
Centers for Disease Control and Prevention (CDC). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014 Clinical Practice Guideline. Available at: http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf (2014, 13 January 2015).
ArnoldEARebchookGMKegelesSM. ‘Triply cursed': racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black gay men. Cult Health Sex2014; 16: 710–722.
20.
BirdJDPViosinDR. “You’re an open target to be abused”: a qualitative study of stigma and HIV self-disclosure among black men who have sex with men. Am J Public Health2013; 103: 2193–2199.
21.
GambleVN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health1997; 87: 1773–1778.
22.
ThomasSBCrouse-QuinnS. Public health then and now. The Tuskegee syphilis study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the Black community. Am J Public Health1991; 81: 1498–1504.
23.
BogartLMThorburnS. Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans. J Acquir Immune Defic Syndr2005; 38: 213–218.
24.
HutchinsonABBegleyEBSullivanP, et al.Conspiracy beliefs and trust in information about HIV/AIDS among minority men who have sex with men. J Acquir Immune Defic Syndr2007; 45: 603–605.
25.
BrooksRAKaplanRLLieberE, et al.Motivators, concerns, and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care2011; 23: 1136–1145.
26.
GolubSAGamarelKERendinaHJ, et al.From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs2013; 27: 248–254.
27.
KrakowerDSMimiagaMJRosenbergerJG, et al.Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLOS ONE2012; 7: e33119–e33119.
28.
MimiagaMJCasePJohnsonCV, et al.Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr2009; 50: 77–83.
29.
SmithDKToledoLSmithDJ, et al.Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev2012; 24: 408–421.
30.
AbbasULAndersonRMMellorsJW. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS ONE2007; 2: e875–e875.
31.
JuusolaJLBrandeauMLOwensDK, et al.The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med2012; 156: 541–550.
32.
AndersonPLGliddenDVLiuA, et al.Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med2012; 4: 151ra125–151ra125.
33.
McEachanRRCConnerMTaylorNJ, et al.Prospective prediction of health related behaviours with the Theory of Planned Behaviour: a meta-analysis. Health Psychol Rev2011; 5: 97–144.
34.
SanchezTFinlaysonTDrakeA, et al.Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors – United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003 – April 2005. MMWR Surveill Summ2006; 55: 1–16.
35.
BrooksRALandovitzRJKaplanRL, et al.Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care and STDs2012; 2: 87–94.
36.
KoenigLJLylesCSmithDK. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prevent Med2013; 44(Suppl 2): S91–S98.
37.
Al TayyibAThrunMWHaukoosJS, et al.Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver, Colorado. AIDS Behav2014; 18(Suppl 3): 340–347.
38.
BauermeisterJAMeanleySPingelE, et al.PrEP awareness and perceived barriers among single young men who have sex with men. Curr HIV Res2013; 11: 520–527.
39.
RucinskiKBMensahNPSepkowitzKA, et al.Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav2013; 17: 2180–2184.
40.
GalindoGRWalkerJJHazeltonP, et al.Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci2012; 7: 116–121.
41.
EatonLADriffinDSmithH, et al.Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sex Health2014; 11: 244–251.
42.
Des JarlaisDCPaoneDMillikenJ, et al.Audiocomputer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet1999; 353: 1657–1661.
43.
TurnerCFKuLRogersSM, et al.Adolescent sexual behavior, drug use and violence: increased reporting with computer survey technology. Science1998; 280: 867–873.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
